What Is Biomerica, Inc. (BMRA) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Biomerica, Inc. presents a highly debated valuation profile at its current price of $1.67. The composite intrinsic value is estimated at $1.86 (+11.7% average upside), masking a wide model spread between the 6 bullish models and 3 bearish models. Model dispersion is worth noting: Regime Cross targets $2.88 (+72.8%), versus EPV at $0.75 (-55.1%). This +127.9% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About BMRA?
11 of 13 models are currently active for BMRA. Of these, 7 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates BMRA's intrinsic value at $0.87, implying -47.5% downside from the current price. See which stocks rank higher →
How Does BMRA Rank in In Vitro & In Vivo Diagnostic Substances?
Among 17 In Vitro & In Vivo Diagnostic Substances stocks, BMRA ranks #11 by Quality of Company score. CirclFi's QOC score of 5.7/10 evaluates 32 fundamental signals. A score of 5.7 reflects mixed fundamentals.
Biomerica, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is BMRA a Value Trap?
CirclFi's Value Trap algorithm assigns BMRA a score of 27/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for Biomerica, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Biomerica, Inc. scores 5.7 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +127.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every BMRA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across BMRA's 11 active models, average confidence is 26%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad